New Zealand markets open in 2 hours 54 minutes

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
60.65-26.30 (-30.25%)
As of 03:06PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 52.40B
Enterprise value 51.10B
Trailing P/E 36.38
Forward P/E 32.05
PEG ratio (5-yr expected) 3.55
Price/sales (ttm)9.17
Price/book (mrq)7.04
Enterprise value/revenue 8.89
Enterprise value/EBITDA 34.71

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 35.18%
S&P500 52-week change 319.61%
52-week high 396.12
52-week low 360.52
50-day moving average 388.99
200-day moving average 381.66

Share statistics

Avg vol (3-month) 32.82M
Avg vol (10-day) 33.37M
Shares outstanding 5602.6M
Implied shares outstanding 6609.11M
Float 8596.1M
% held by insiders 10.89%
% held by institutions 184.58%
Shares short (15 Jul 2024) 47.7M
Short ratio (15 Jul 2024) 42.28
Short % of float (15 Jul 2024) 41.29%
Short % of shares outstanding (15 Jul 2024) 41.28%
Shares short (prior month 14 Jun 2024) 48.19M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 301 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 23.74%
Operating margin (ttm)26.63%

Management effectiveness

Return on assets (ttm)12.27%
Return on equity (ttm)22.02%

Income statement

Revenue (ttm)6.2B
Revenue per share (ttm)10.27
Quarterly revenue growth (yoy)-9.40%
Gross profit (ttm)N/A
EBITDA 2.03B
Net income avi to common (ttm)1.54B
Diluted EPS (ttm)2.39
Quarterly earnings growth (yoy)19.30%

Balance sheet

Total cash (mrq)1.99B
Total cash per share (mrq)3.31
Total debt (mrq)693M
Total debt/equity (mrq)9.23%
Current ratio (mrq)3.71
Book value per share (mrq)12.35

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A